WeVote
Log In

Bill

Bill

LC 4318

Generally revise administration of drug and substance laws

2025 Regular Session

Overhauls how state drug and alcohol laws are administered, reshaping agency roles, licensing, enforcement, and public health programs.

(LC) Draft in Assembly
#alcoholanddrugs
0
WeVote Research Nonpartisan
Bill Summary · LC 4318

Summary: LC 4318 — Generally revise administration of drug and substance laws

At a glance

  • Bill number: LC 4318
  • Title: Generally revise administration of drug and substance laws
  • Status: Draft in Assembly (LC)
  • Introduced: January 16, 2025
  • Subject: Alcohol and Drugs
  • Primary purpose (as stated): To generally revise the administration of drug and substance laws

What is known about the bill

  • The full text of LC 4318 is not provided here. Based on the title and current status, the bill is intended to overhaul how drug- and substance-related laws are administered. The scope could involve regulatory structures, oversight, licensing, enforcement, public health programs, and related administrative processes. No specific provisions, definitions, or numeric changes are available in the information provided.

Potential provisions (typical areas in this category)

Because the actual text is not yet public, possible areas such a bill commonly addresses (but not guaranteed to appear in LC 4318) may include:
- Regulatory and licensing framework for entities involved in alcohol and controlled substances
- Changes to agency responsibilities and interagency coordination
- Administrative rulemaking procedures, public notice, and comment processes
- Enforcement authority, penalties, and compliance timelines
- Data sharing, reporting requirements, and outcome metrics
- Transitional provisions for existing licenses and programs
- Public health and harm-reduction considerations (where applicable)
- Definitions clarifying terms used across drug- and alcohol-related laws
- Fiscal and staffing implications for implementing changes

Who would be affected

  • State agencies and boards responsible for regulating drugs, alcohol, and related substances under state law
  • Licensees and permit holders (e.g., manufacturers, distributors, retailers, treatment providers, clinics)
  • Law enforcement and regulatory personnel enforcing drug- and alcohol-related statutes
  • Public health systems and service providers that administer harm-reduction, treatment, and prevention programs
  • General public and consumers impacted by changes in access, safety standards, and enforcement practices

Procedural and timeline considerations

  • Current status indicates the bill is in the Assembly drafting phase, with actions recorded as:
    • January 16, 2025 — Drafter assigned
    • January 19, 2025 — Draft in Edit
    • February 19, 2025 — Draft in Legal Review and Input/Proofing
    • February 24, 2025 — Final Drafter Review; Draft in Assembly
  • After Assembly consideration, the bill would typically proceed to the Senate (or equivalent chamber), potentially undergo committee hearings, votes, and, if approved, proceed to the governor for signature or veto. Fiscal notes may be generated as the text advances.

Next steps for interested readers

  • Monitor official bill text and amendments as they become publicly available.
  • Track committee hearings and voting records to understand support, opposition, and specific provisions.
  • Review any attached fiscal notes to gauge anticipated costs or savings and potential impacts on agencies and stakeholders.

If you’d like, I can incorporate the actual text and provide a detailed section-by-section summary once the bill’s full language is released.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.